Advanced Drug Delivery Systems Market

Advanced drug delivery systems (DDS) present indubitable benefits for drug administration. ADDS are delivery systems which are based on the principles of novel drug delivery systems and use the latest and most advanced technologies. ADDS refer to technologies used to control the rate of drug release. Advanced drug delivery systems offer convenient options to patients, such as easy drug administration, short administration time, dose accuracy, improved patient adherence, among others. The system is designed to deliver a drug in a controlled way within the tissue or cells and aimed at safe and effective medication.

Market Dynamics:

Increase in prevalence of chronic diseases, rise in adoption of improved drug delivery solutions, increasing innovations in injectable drug delivery systems, growing inclination toward self-administration of drugs, and increase in research and development activities are major factors expected to boost the growth of the advanced drug delivery systems market. ADDS are carriers for a wide range of pharmacotherapies used in many applications, including cancer treatment. The use of such carrier systems in cancer treatment is growing rapidly as they help overcome the limitations associated with conventional drug delivery systems. Thus, with the increase in prevalence of cancer, the use of ADDS is also increasing.

Cancer continues to be the second most common cause of death in the U.S., after heart disease. According to the American Cancer Society, in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States.

Key features of the study:

• This report provides in-depth analysis of the global advanced drug delivery systems market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global advanced drug delivery systems market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Amgen Inc., Glaxosmithkline, Celgene Corporation, Boston Scientific, Baxter International, Astrazeneca, Astellas Pharma, 3M Company, Abbott Laboratories, and Bayer Healthcare, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global advanced drug delivery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global advanced drug delivery systems market.

Detailed Segmentation:

• Global Advanced Drug Delivery Systems Market, By Type:
• • Oral Drug Delivery System
  • Injection-Based Drug Delivery System
  • Inhalation/Pulmonary Drug Delivery System
  • Transdermal Drug Delivery System
  • Transmucosal Drug Delivery System
  • Carrier Based Drug Delivery System
  • Others
• Global Advanced Drug Delivery Systems Market, By Application:
• • Cardiovascular Diseases
  • Oncology
  • Urology
  • Diabetes
  • CNS
  • Ophthalmology
  • Inflammatory diseases
  • Infections
  • Others
• Global Advanced Drug Delivery Systems Market, By Technology:
• • Prodrug
  • Implants and Intrauterine Devices
  • Targeted Drug Delivery
  • Polymeric Drug Delivery
  • Others
• Global Advanced Drug Delivery Systems Market, By Geography:
• • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
• • Amgen Inc.
  • Glaxosmithkline
  • Celgene Corporation
  • Boston Scientific
  • Baxter International
  • Astrazeneca
  • Astellas Pharma
  • 3M Company
  • Abbott Laboratories
  • Bayer Healthcare